Structure Therapeutics (GPCR) Equity Average (2022 - 2026)
Quarterly Equity Average rose 75.41% to $1.5 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.5 billion through Mar 2026, up 75.41% year-over-year, with the annual reading at $1.2 billion for FY2025, 80.7% up from the prior year.
Structure Therapeutics' Equity Average history spans 5 years, with the latest figure at $1.5 billion for Q1 2026.
- Equity Average came in at $1.5 billion for Q1 2026, up from $1.1 billion in the prior quarter.
- In the past five years, Equity Average ranged from a high of $1.5 billion in Q1 2026 to a low of -$109.5 million in Q4 2022.
- The 5-year median for Equity Average is $558.4 million (2024), against an average of $529.1 million.
- Year-over-year, Equity Average soared 628.3% in 2024 and then decreased 15.17% in 2025.
- Structure Therapeutics' Equity Average stood at -$109.5 million in 2022, then soared by 394.87% to $323.0 million in 2023, then surged by 172.73% to $880.8 million in 2024, then increased by 29.79% to $1.1 billion in 2025, then increased by 29.61% to $1.5 billion in 2026.
- Per Business Quant, the three most recent readings for GPCR's Equity Average are $1.5 billion (Q1 2026), $1.1 billion (Q4 2025), and $771.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 3.76 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 21.35 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 19.01 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 31.34 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 932.28 Mn |
| 10 | Structure Therapeutics | 8.43 Bn | 8.43 Bn | - | 1.48 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.48 Bn |
| Dec 31, 2025 | 1.14 Bn |
| Sep 30, 2025 | 771.05 Mn |
| Jun 30, 2025 | 798.36 Mn |
| Mar 31, 2025 | 844.74 Mn |
| Dec 31, 2024 | 880.82 Mn |
| Sep 30, 2024 | 908.92 Mn |
| Jun 30, 2024 | 675.43 Mn |
| Mar 31, 2024 | 441.39 Mn |
| Dec 31, 2023 | 322.97 Mn |
| Sep 30, 2023 | 203.69 Mn |
| Jun 30, 2023 | 225.38 Mn |
| Mar 31, 2023 | 60.61 Mn |
| Dec 31, 2022 | -109.53 Mn |
| Sep 30, 2022 | -98.01 Mn |
| Jun 30, 2022 | -84.67 Mn |